£234.00

Springer Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£234 today · previous high £234 · all-time low £234

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days • 77 data points (No recent data available)

Historical
Generating forecast...
£234.00 £233.95 £233.96 £233.97 £233.98 £233.99 £234.01 22 February 2026 13 March 2026 01 April 2026 20 April 2026 09 May 2026

Price Distribution

Price distribution over 77 days • 1 price levels

Days at Price
77 days 0 19 39 58 77 £234 Days at Price

Price Analysis

Most common price: £234 (77 days, 100.0%)

Price range: £234 - £234

Price levels: 1 different prices over 77 days

Description

Taken together the data presented in this review, and work by many other investigators, support the notion that DNA excision repair is important in a tumor cell's resistance to platinum compounds. Inhibition of this repair system by combination chemotherapy with the excision repair inhibitors HU and Ara-C produces synergistic cell kills and increased levels and persistance of DNA interstrand crosslinks. The studies with cis-DDP and ~-DDP in combination with UV induced thymine dimers suggest that there may be competition for DNA repair enzymes between the dimer and the platinum lesion. Whether the competing lesion is an intrastrand crosslink, interstrand crosslink, or platinum monoadduct (or all of these lesions) cannot be determined. The similarity between an intrastrand crosslink and a cyclobutane dimer suggests that these lesions may compete for repair. However, the increased peak levels of interstrand crosslinks, and increased persistence of these lesions at later time points suggest that this lesion may also be a substrate for the repair system. These observations may be of clinical relevance. Recently Dr. Kathy Albain of our institution has completed a Phase III I study using a 12 hour pretreatment with HU and Ara-C in patients prior to their cis-DDP therapy. She observed a significant number of responders in this trial (54). She is currently completing a second Phase IIII study substituting IV HU for the oral formulation. We anticipate initiating other clinical trials based upon these observations.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
29 February 1992
Listed Since
12 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy
99% match

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

Springer

£227.53 08 May 2026
Targeting the DNA Damage Response for Anti-Cancer Therapy (Cancer Drug Discovery and Development)
96% match

Targeting the DNA Damage Response for Anti-Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£147.01 04 May 2026
Humana - Targeting the DNA Damage Response for Anti-Cancer Therapy
96% match

Humana - Targeting the DNA Damage Response for Anti-Cancer Therapy

Humana

£147.11 29 Apr 2026
PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development)
96% match

PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£112.83 03 May 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
96% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£18.99 22 Jan 2026
Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)
96% match

Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)

Springer

£166.14 24 Apr 2026
Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)
96% match

Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)

Springer

£149.64 19 Apr 2026
Humana DNA Damage and Repair - Contemporary Cancer Research
96% match

Humana DNA Damage and Repair - Contemporary Cancer Research

Humana

£113.76 19 Apr 2026
Humana Anticancer Drug Development Guide - Cancer Drug Discovery
96% match

Humana Anticancer Drug Development Guide - Cancer Drug Discovery

Humana

£49.16 26 Apr 2026
Humana Anticancer Drug Development Guide - Oncology Textbook
96% match

Humana Anticancer Drug Development Guide - Oncology Textbook

Humana

£110.18 23 Apr 2026
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
96% match

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Springer

£113.48 19 Apr 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
95% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£165.95 09 Apr 2026
p53 in the Clinics
95% match

p53 in the Clinics

Springer

£80.09 05 Mar 2026
Advances in Cancer Research: v. 87: Vol. 87: Volume 87
95% match

Advances in Cancer Research: v. 87: Vol. 87: Volume 87

Academic Press

£88.19 09 Mar 2026
Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer
95% match

Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer

WOLTERS KLUWER HEALTH

£55.30 06 Feb 2026
The Oncogenomics Handbook (Cancer Drug Discovery and Development)
95% match

The Oncogenomics Handbook (Cancer Drug Discovery and Development)

Humana

£34.76 29 Apr 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
95% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£148.69 13 Jan 2026
Wiley Anticancer Therapeutics - Oncology Drug Design Book
95% match

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Wiley

£133.27 15 Apr 2026
Springer Advances in Molecular Oncology: 604 - Science Book
95% match

Springer Advances in Molecular Oncology: 604 - Science Book

Springer

£105.49 12 May 2026
Molecular Biology of Human Cancers
95% match

Molecular Biology of Human Cancers

£76.67 12 Jan 2026
Molecular Biology of Human Cancers
95% match

Molecular Biology of Human Cancers

£96.11 13 Jan 2026
Cancer Chemotherapy: Basic Science to the Clinic
95% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley-Blackwell

£47.19 16 Feb 2026
Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)
95% match

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Springer

£61.40 15 Apr 2026
Free-Radical-Induced DNA Damage and Its Repair: A Chemical Perspective
95% match

Free-Radical-Induced DNA Damage and Its Repair: A Chemical Perspective

Springer

£180.00 15 Dec 2025